Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new windowYouTube page opens in new window
[email protected]+61 3 9692 7222
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT

Financial Reports

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Appendix 4C & Quarterly Update

30/04/2024
Click to view

Appendix 4D & Half-Year Report

29/02/2024
Click to view

Appendix 4C & Quarterly Update

31/01/2024
Click to view

Appendix 4C and Quarterly Update

30/10/2023
Click to view

Appendix 4E & Full Year Statutory Accounts

31/08/2023
Click to view

Appendix 4C and Quarterly Update

31/07/2023
Click to view

Appendix 4C and Quarterly Update

28/04/2023
Click to view

Appendix 4D & Half Year Report

27/02/2023
Click to view

Appendix 4C and Quarterly Update

31/01/2023
Click to view

October 31, Appendix 4C and Quarterly Update

Financial Reports 2022By Nickholas Bahr31/10/2022
Read more

August 26, Appendix 4E & Full Year Statutory Accounts

Financial Reports 2022By Nickholas Bahr26/08/2022
Read more

July 20, Appendix 4C and Quarterly Update

Financial Reports 2022By Nickholas Bahr20/07/2022
Read more

April 29, Appendix 4C and Quarterly Update

Financial Reports 2022, News & Announcements 2022By PharmAust29/04/2022

220409_A4C_quarterly update

Read more

February 18, Appendix 4D and Half Year Update

Financial Reports 2022, News & Announcements 2022By PharmAust18/02/2022

220218_Appendix4D and Half Year Update

Read more

January 31, Appendix 4C and Quarterly Update

Financial Reports 2022By Nickholas Bahr31/01/2022
Read more

August 18, Appendix 4G

Financial Reports 2021, News and Announcements 2021By PharmAust18/08/2021

210818_Appendix 4G

Read more

August 18, Appendix 4E

Financial Reports 2021, News and Announcements 2021By PharmAust18/08/2021

210818_Appendix 4E

Read more

July 28, Appendix 4C and Quarterly Update

Financial Reports 2021, News and Announcements 2021By PharmAust28/07/2021

210728_Appendix 4C and Q Update

Read more

April 29, Appendix 4C and Quarterly Update

Financial Reports 2021, News and Announcements 2021By PharmAust29/04/2021

210429_Appendix 4C and Quarterly Update

Read more

February 26, Appendix 4D & Half Year Report

Financial Reports 2021, News and Announcements 2021By PharmAust26/02/2021

210226_Appendix 4D, half yearly report

Read more

30 April, Appendix 3G Notification of Issue, Conversion or Payment of Equity + Securities

Financial Reports 2020, News & Announcements 2020By PharmAust30/04/2020

200430_Performance rights

Read more

20 April, Appendix 4C and Quarterly Update

Financial Reports 2020, News & Announcements 2020By PharmAust20/04/2020

200420_Appendix 4C and Quarterly Update

Read more

31 March, Expiry of Options

Financial Reports 2020, News & Announcements 2020By PharmAust31/03/2020

200313_Expiry of Options

Read more

28 Feb, Appendix 4D & Half Year Report

Financial Reports 2020, News & Announcements 2020By PharmAust28/02/2020

200228_Appendix 4D & Half Year Report

Read more

28 January, Appendix 4C and Quarterly Update

Financial Reports 2020, News & Announcements 2020By PharmAust28/01/2020

200128_Appendix 4C and Quarterly Update

Read more

Appendix 3B, Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAust19/11/2019

191121_Exercise of Options

Read more

Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAust08/11/2019

191108_Appendix 3B – Exercise of Options

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By PharmAust01/11/2019

191101_Appendix 4C and Quarterly Update

Read more

Appendix 3B & s708 Notice

Financial Reports 2019, News & Announcements 2019By PharmAust10/10/2019

191010_Appendix 3B & s708 Notice

Read more

26 September, Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAust26/09/2019

190926_Exercise of Options

Read more

19 September: Appendix 4G & Corporate Governance Statement

Financial Reports 2019, News & Announcements 2019By PharmAust23/09/2019

190919_Appendix 4G & Corporate Governance Statement

Read more

19 September: Annual_Report

Financial Reports 2019, News & Announcements 2019By PharmAust19/09/2019

190919_Annual_Report

Read more

17 September: Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAust17/09/2019

190917_Appendix 3B Exercise of Options

Read more

Appendix 4E Preliminary Final Report

Financial Reports 2019, News & Announcements 2019By PharmAust30/08/2019

190830_Preliminary Final Report

Read more

Appendix 3B and s708 Notice

Financial Reports 2019, News & Announcements 2019By PharmAust28/08/2019

190828_Appendix 3B & s708 notice

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By PharmAust30/07/2019

4471277nx3858c

Read more

Appendix 3B & s708 Notice

Financial Reports 2019, News & Announcements 2019By PharmAust26/07/2019

190729_Unlisted Options Issuance

Read more

23 July 2019, Change in Substantial Holding

Financial Reports 2019, News & Announcements 2019By PharmAust23/07/2019

Change in Substantial Holding

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By PharmAust01/05/2019

444r10lc14lvz2

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By PharmAust24/04/2019

Appendix 3B

Read more

Appendix 4D and Financial Report

Financial Reports 2019, News & Announcements 2019By PharmAust01/03/2019

190301_Appendix-4D-and-Financial-Report

Read more

Section 708A

Financial Reports 2019, News & Announcements 2019By PharmAust18/02/2019

190218_Section 708A

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By PharmAust18/02/2019

190218_Appendix 3B

Read more

Appendix 3B Amendment

Financial Reports 2019, News & Announcements 2019By PharmAust14/02/2019

190214_Appendix 3B Amendment

Read more

Section 708A

Financial Reports 2019, News & Announcements 2019By PharmAust07/02/2019

190207_Section 708A

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By PharmAust07/02/2019

190207_Appendix 3B

Read more

December 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2019, News & Announcements 2019By PharmAust31/01/2019

190131_4C

Read more

Top 20 Shareholders December 2022

01/01/2023

Top 20 Shareholders November 2022

01/12/2022

September 2018 Appendix 4C Quarterly Report and Company Update

01/11/2018

PharmAust 2018 Annual Report

01/10/2018

Preliminary Final Statements to the ASX

03/09/2018

Top 20 Shareholders August 2018

17/08/2018

Top 20 Shareholders July 2018

13/07/2018

Top 20 Shareholders June 2018

10/06/2018

PharmAust Appendix 4C and Shareholders Update (Q3, 2018 FY)

01/05/2018

Top 20 Shareholders April 2018

27/04/2018

SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001

20/03/2018

Appendix 3B: New issue announcement, application for quotation of additional securities and agreement

16/03/2018

Appendix 3Y: Change of Director’s Interest Notice

16/03/2018

Appendix 4D – Half Yearly Report for Dec, 2017

01/03/2018

Top 20 Shareholders Feb 2018

26/02/2018

Results of General Meeting

26/02/2018

Appendix 4C and Shareholders Update (Q2, 2018 FY)

31/01/2018

NOTICE OF GENERAL MEETING AND EXPLANATORY STATEMENT

29/01/2018

December 1, Demonstration Batch Small MPL Tablets Completed

01/12/2021

November 15, New Zealand Joins Phase 2B Pet Dog Trial

15/11/2021

Top 20 Shareholders December 2017

15/12/2017

Results of AGM 2017

01/12/2017

Trading Halt Request

01/12/2017

AGM Presentation 2017

01/12/2017

AGM notice

01/11/2017

Appendix 4C – Quarterly Report and Company Update for the period ended 30 September 2017

30/09/2017

Appendix 4G

31/08/2017

Appendix 4E & Annual Report

10/07/2017

Appendix 4C – Quarterly Report & Company Update for the period ended 30 June 2017

30/06/2017

Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017

13/04/2017

Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016

31/01/2017

Appendix 4D Half-Year Report for the period ended 31 December 2016

31/12/2016

Appendix 4D Half-Year Report for the period ended 31 December 2016

31/12/2016

Appendix 4D & Half Yearly Report and Accounts

31/12/2016

Results of annual general meetings

11/11/2016

Appendix 3B

11/11/2016

Notice of annual general meeting and explanatory statement

11/11/2016

Appendix 4C – Quarterly Report & Company Update for the period ended 30 September 2016

31/10/2016

Appendix 4E Annual Report & Full Year Statutory Accounts 2016

01/07/2016

Appendix 4G & Corporate Governance Statement

30/06/2016

Appendix 4C Quarterly Report & Brief Company Update

29/04/2016

Appendix 4C – Quarterly Report & Company Update

29/01/2016

Appendix 3B

05/11/2015

Appendix 4C Quarterly Report & Company Update

30/10/2015

Results of Annual General Meetings 2015

27/10/2015

PharmAust Annual Report 2015

28/08/2015

Appendix 4G & Corporate Governance Statement

30/06/2015

Appendix 4E & Full Year Statutory Accounts

30/06/2015

Appendix 4C – Quarterly Report & Company Update

30/06/2015

Results of Meeting

26/05/2015

Notice of General Meeting_Proxy Form

26/05/2015

Appendix 4C Quarterly Report & Company Update

31/03/2015

Clarification to Quarterly Report & Company Update

03/02/2015

Appendix 4C – Quarterly Report & Company Update

30/01/2015

Shareholder Update – Human & Canine Trials

25/01/2015

Appendix 4D and Half Yearly Report & Accounts

31/12/2014
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

PharmAust Follow

PharmAust is a clinical-stage biotech company focused on repurposing monepantel (MPL) for human neurodegenerative diseases ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
24 Jun 2024

📸 Highlights from the MND Australia Global Day Event at Parliament House!

We teamed up with FightMND to raise awareness and fight for a future free of Motor Neurone Disease. 💙

#MNDAustralia #FightMND #MNDGlobalDay

Reply on Twitter 1805134834358210569 Retweet on Twitter 1805134834358210569 2 Like on Twitter 1805134834358210569 12 Twitter 1805134834358210569
Retweet on Twitter PharmAust Retweeted
stockheadau Stockhead @stockheadau ·
21 Jun 2024

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
#ASX @PharmAust

Reply on Twitter 1803984607676654065 Retweet on Twitter 1803984607676654065 1 Like on Twitter 1803984607676654065 3 Twitter 1803984607676654065
pharmaust PharmAust @pharmaust ·
21 Jun 2024

Exciting news for our investors! 🎉 Check out the details of our latest capital raise here: https://investorhub.pharmaust.com/investment-offer/32. Thank you for your continued support! 🌟 #PharmAust

Reply on Twitter 1804030728956711230 Retweet on Twitter 1804030728956711230 2 Like on Twitter 1804030728956711230 7 Twitter 1804030728956711230
Load More

Copyright © 2025 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top